297 related articles for article (PubMed ID: 34391573)
1. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.
Ahn JH; Kwak JH; Yoon SG; Yi JW; Yu HW; Kwon H; Kim SJ; Lee KE
Surgery; 2022 Jan; 171(1):182-189. PubMed ID: 34391573
[TBL] [Abstract][Full Text] [Related]
2. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward.
Dismukes J; Fazendin J; Obiarinze R; Márquez GCH; Ramonell KM; Buczek E; Lindeman B; Chen H
J Surg Res; 2021 Aug; 264():230-235. PubMed ID: 33838407
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy of Intraoperative Ultrasound for Prophylactic Lymphadenectomy of the Lateral Cervical Neck in Stage CN0 Papillary Thyroid Cancer: A Prospective Study.
Shen Y; Li X; Tao L; Chen Y; Xie R
J Invest Surg; 2023 Dec; 36(1):2154416. PubMed ID: 36519315
[No Abstract] [Full Text] [Related]
5. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.
Viola D; Materazzi G; Valerio L; Molinaro E; Agate L; Faviana P; Seccia V; Sensi E; Romei C; Piaggi P; Torregrossa L; Sellari-Franceschini S; Basolo F; Vitti P; Elisei R; Miccoli P
J Clin Endocrinol Metab; 2015 Apr; 100(4):1316-24. PubMed ID: 25590215
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
8. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
9. Role of Prophylactic Central Compartment Lymph Node Dissection on the Outcome Of Patients With Papillary Thyroid Carcinoma and Synchronous Ipsilateral Cervical Lymph Node Metastases.
De Napoli L; Matrone A; Favilla K; Piaggi P; Galleri D; Ambrosini CE; Aghababyan A; Papini P; Valerio L; Viola D; Torregrossa L; Ugolini C; Proietti A; Basolo F; Miccoli P; Elisei R; Materazzi G
Endocr Pract; 2020 Aug; 26(8):807-817. PubMed ID: 33471672
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
11. Lymph Node Dissection for Papillary Thyroid Carcinoma.
Lo CY
Methods Mol Biol; 2022; 2534():57-78. PubMed ID: 35670968
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.
Conzo G; Docimo G; Pasquali D; Mauriello C; Gambardella C; Esposito D; Tartaglia E; Della Pietra C; Napolitano S; Rizzuto A; Santini L
BMC Surg; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 24267409
[TBL] [Abstract][Full Text] [Related]
13. Preferential Use of Total Thyroidectomy without Prophylactic Central Lymph Node Dissection for Early-Stage Papillary Thyroid Cancer: Oncologic Outcomes in an Integrated Health Plan.
Said M; Fujimoto M; Franken C; Woo S; Vuong B; Haigh PI
Perm J; 2016; 20(4):15-251. PubMed ID: 27723445
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
So YK; Seo MY; Son YI
Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract][Full Text] [Related]
17. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection.
Yoo HS; Shin MC; Ji YB; Song CM; Lee SH; Tae K
Asian J Surg; 2018 Jul; 41(4):363-369. PubMed ID: 28454667
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers.
Yang Z; Heng Y; Lin J; Lu C; Yu D; Tao L; Cai W
Cancer Res Treat; 2020 Oct; 52(4):1010-1018. PubMed ID: 32599980
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic bilateral central neck dissection should be evaluated based on prospective randomized study of 581 PTC patients.
Yan S; Yu J; Zhao W; Wang B; Zhang L
BMC Endocr Disord; 2022 Jan; 22(1):5. PubMed ID: 34983475
[TBL] [Abstract][Full Text] [Related]
20. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
